| Financial Year |
March 31 2023 |
| Monetary Funds |
3,861,549,190.00 |
| Held-for-trading Financial Assets |
146,308,120.00 |
| Notes Receivable |
454,618,910.00 |
| Accounts Receivable |
391,100,080.00 |
| Advances to Suppliers |
140,798,840.00 |
| Other Receivables |
43,737,900.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
473,424,640.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
101,750,170.00 |
| Other Current Assets |
26,499,050.00 |
| Total Current Assets |
5,727,808,250.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,442,920.00 |
| Long-term Equity Investment |
58,951,650.00 |
| Investment Properties |
52,194,210.00 |
| Fixed Assetes |
1,964,154,010.00 |
| Under-construction Projects |
331,777,720.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
1,779,015,540.00 |
| Intangible Assets |
642,998,650.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
63,230,840.00 |
| Other Non-Current Assets |
470,671,590.00 |
| Sub-Total of Non-Current Assets |
5,491,701,420.00 |
| Total Assets |
11,219,509,670.00 |
| Short-Term Loans |
1,108,230,050.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,074,360.00 |
| Accounts Payable |
113,820,350.00 |
| Accounts Received In Advance |
568,550.00 |
| Employee Compensation Payable |
168,110,540.00 |
| Taxes Payable |
113,808,010.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,456,044,910.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
221,867,820.00 |
| Other Current Liabilities |
300,766,430.00 |
| Sub-Total of Current Liabilities |
3,623,289,070.00 |
| Long-term Loans |
423,894,400.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
220,242,860.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
154,167,450.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,185,974,840.00 |
| Total Liabilities |
4,809,263,910.00 |
| Paid-In Capital(Or Share Stock) |
2,037,954,530.00 |
| Capital Surplus |
3,825,139,520.00 |
| Surplus Reserve |
484,599,850.00 |
| LESS:Treasury Stock |
87,115,010.00 |
| Undistributed Profits |
154,227,460.00 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,410,245,760.00 |
| Owner's Equity（Stockholder's Equity） |
6,410,245,760.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,219,509,670.00 |
